Name: UMIN ID:
Unique ID issued by UMIN | UMIN000020398 |
---|---|
Receipt number | R000016543 |
Scientific Title | Regenerative medicine using bone marrow-derived mesenchymal cells for maxillomandibular bone defect. |
Date of disclosure of the study information | 2016/01/15 |
Last modified on | 2023/02/23 13:38:54 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2015/12/29 19:47:31 | ||
2 | Update | 2016/05/10 15:40:00 | Name of primary person or sponsor Institute Department Organization Organization Category of Funding Organization |
|
3 | Update | 2016/05/10 15:40:46 | Recruitment status Anticipated trial start date |
|
4 | Update | 2016/05/27 18:43:44 | UMIN ID2 |
|
5 | Update | 2016/08/08 08:52:05 | Last name of lead principal investigator Last name of lead principal investigator Last name of contact person Last name of contact person Organization Organization Division name Division name |
|
6 | Update | 2017/07/10 16:03:51 | Organization1 Tel1 Email1 |
|
7 | Update | 2017/07/10 16:04:31 | Recruitment status |
|
8 | Update | 2018/07/11 18:47:24 | Key exclusion criteria Key exclusion criteria |
|
9 | Update | 2018/07/11 18:49:47 | Last name of lead principal investigator Last name of lead principal investigator Organization Organization Division name Division name |
|
10 | Update | 2018/08/14 13:18:22 | UMIN ID3 |
|
11 | Update | 2019/02/14 22:09:45 | Key exclusion criteria Key exclusion criteria |
|
12 | Update | 2019/02/14 22:10:43 | TEL |
|
13 | Update | 2020/08/26 12:03:12 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address TEL Last name of contact person Last name of contact person Division name Division name Zip code Address TEL Division name Division name Organization Organization Address Address Tel Secondary IDs Study ID_1 Org. issuing International ID_1 Org. issuing International ID_1 |
|
14 | Update | 2020/08/26 12:06:11 | Recruitment status Date of IRB Last follow-up date |
|
15 | Update | 2023/02/23 13:27:52 | URL releasing protocol Number of participants that the trial has enrolled |
|
16 | Update | 2023/02/23 13:36:17 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
17 | Update | 2023/02/23 13:38:54 | 1st name of lead principal investigator Last name of lead principal investigator TEL TEL |